141 related articles for article (PubMed ID: 6998900)
1. Effect of pathological conditions on drug penetration into the anterior segment.
Foulks GN
Int Ophthalmol Clin; 1980; 20(3):51-9. PubMed ID: 6998900
[No Abstract] [Full Text] [Related]
2. Structures and fluids involved in the penetration of topically applied drugs.
Maurice DM
Int Ophthalmol Clin; 1980; 20(3):7-20. PubMed ID: 6998902
[No Abstract] [Full Text] [Related]
3. Clinical pharmacology of the anterior segment.
Int Ophthalmol Clin; 1980; 20(3):1-194. PubMed ID: 7419370
[No Abstract] [Full Text] [Related]
4. Pharmacokinetics of instilled drugs in the human eye.
Nagataki S; Mishima S
Int Ophthalmol Clin; 1980; 20(3):33-49. PubMed ID: 6998899
[No Abstract] [Full Text] [Related]
5. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2019; 35(1):1-2. PubMed ID: 30566384
[No Abstract] [Full Text] [Related]
6. [Pharmaco-toxicological aspects of ophthalmological medication].
Cristea E
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1985; 29(2):135-40. PubMed ID: 3161128
[No Abstract] [Full Text] [Related]
7. Factors influencing the penetration of topically applied drugs.
Maurice DM
Int Ophthalmol Clin; 1980; 20(3):21-32. PubMed ID: 6998898
[No Abstract] [Full Text] [Related]
8. [Environmental pH and corneal oxygen flux (author's transl)].
Carney LG; Efron N
J Fr Ophtalmol; 1980; 3(2):125-6. PubMed ID: 7381179
[TBL] [Abstract][Full Text] [Related]
9. Ocular pharmacology and therapeutics.
Evans TM
J Occup Med; 1971 Feb; 13(2):92-6. PubMed ID: 5546201
[No Abstract] [Full Text] [Related]
10. Comparison of the ocular comfort of ofloxacin 0.3% ophthalmic solution and lubricant eye drops.
Roberts C
Clin Pediatr (Phila); 2002 Apr; 41(3):151-4. PubMed ID: 11999678
[No Abstract] [Full Text] [Related]
11. [Experimental ophthalmic anti-inflammatory activity of some steroid and non-steroid drugs topically applied].
Abbondati G; Cornelli U; Preti M; Trimarchi F
Ann Ottalmol Clin Ocul; 1970 Mar; 96(3):161-70. PubMed ID: 5492802
[No Abstract] [Full Text] [Related]
12. Determination of permeability coefficients of ophthalmic drugs through different layers of porcine, rabbit and bovine eyes.
Loch C; Zakelj S; Kristl A; Nagel S; Guthoff R; Weitschies W; Seidlitz A
Eur J Pharm Sci; 2012 Aug; 47(1):131-8. PubMed ID: 22659372
[TBL] [Abstract][Full Text] [Related]
13. Physico-chemical aspects of ophthalmic and contact lens solutions.
Lamy PP; Shangraw RF
Am J Optom Arch Am Acad Optom; 1971 Jan; 48(1):37-51. PubMed ID: 4993499
[No Abstract] [Full Text] [Related]
14. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.
Gause S; Hsu KH; Shafor C; Dixon P; Powell KC; Chauhan A
Adv Colloid Interface Sci; 2016 Jul; 233():139-154. PubMed ID: 26318359
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology and pharmacology of anterior segment surgery.
Mishima S
Yan Ke Xue Bao; 1987 Sep; 3(3):143-7. PubMed ID: 3508398
[No Abstract] [Full Text] [Related]
16. [Biopharmaceutics of eye drugs].
Naumann H
Pharmazie; 1980 Dec; 35(12):814-7. PubMed ID: 7208591
[No Abstract] [Full Text] [Related]
17. Potency and duration of action of synthetic P2Y2 receptor agonists on Schirmer scores in rabbits.
Yerxa BR; Douglass JG; Elena PP; Caillaud T; Amar T; Edick C; Peterson WM
Adv Exp Med Biol; 2002; 506(Pt A):261-5. PubMed ID: 12613918
[No Abstract] [Full Text] [Related]
18. Diquafosol Ophthalmic Solution Increases Pre- and Postlens Tear Film During Contact Lens Wear in Rabbit Eyes.
Nagahara Y; Koh S; Oshita Y; Nagano T; Mano H; Nishida K; Watanabe H
Eye Contact Lens; 2017 Nov; 43(6):378-382. PubMed ID: 27243352
[TBL] [Abstract][Full Text] [Related]
19. Ophthalmic medications and pharmacology.
Duvall B; Kershner RM
J Ophthalmic Nurs Technol; 1998; 17(4):151-8. PubMed ID: 9883136
[No Abstract] [Full Text] [Related]
20. General rules in ocular permeability.
Cambie E
Bull Soc Belge Ophtalmol; 1979; 186():3-8. PubMed ID: 554715
[No Abstract] [Full Text] [Related]
[Next] [New Search]
